Omid Veiseh,Richard Heidebrecht,Paul Kevin Wotton,Matthias Alexander Oberli,Robert James Miller
申请号：
US16339285
公开号：
US20200039943A1
申请日:
2017.10.03
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are implantable elements (e.g., devices and materials) comprising the same, as well as methods of use thereof, e.g., for treating or preventing a disease, disorder, or condition.
